Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Simulations Plus Inc.

LSL Property Services ( ($GB:LSL) ) has shared an announcement. LSL Property Services has reported routine share purchases and allocations under it...

LSL directors receive shares under all-employee incentive scheme

In a report released on July 1, Ben Davis from RBC Capital maintained a Buy rating on Sylvania Platinum, with a price target of p170.00. The compan...

RBC Capital Remains a Buy on Sylvania Platinum (SLP)

LSL Property Services ( ($GB:LSL) ) has provided an update. LSL Property Services plc has disclosed that its Group Chief Executive Officer, Adam Ca...

LSL CEO Increases Stake Through Dividend Reinvestment

LSL Property Services ( ($GB:LSL) ) has shared an update. LSL Property Services has reported routine share purchases by employees and senior manage...

LSL executives boost holdings through dividend reinvestment plan

An update from LSL Property Services ( ($GB:LSL) ) is now available. LSL Property Services, a leading U.K. residential property and mortgage servic...

LSL backs UK homebuying reform roadmap, eyes benefits from modernisation

Simulations Plus ( ($SLP) ) has provided an update. On June 15, 2026, Simulations Plus agreed to be acquired by SP Evolution HoldCo II, an Altaris ...

Simulations Plus to Be Acquired by Altaris Affiliate

Simulations Plus ( ($SLP) ) has issued an announcement. On June 16, 2026, Simulations Plus, Inc., a provider of model‑informed and AI‑accelerated d...

Altaris to Take Simulations Plus Private in Acquisition

LSL Property Services ( ($GB:LSL) ) just unveiled an update. LSL Property Services has reported share transactions involving Paul Hardy, a person d...

LSL Property Services Discloses PDMR Share Transactions Under Long-Term Incentive Plan

The latest announcement is out from LSL Property Services ( ($GB:LSL) ). LSL Property Services has reported routine dealings in its shares under an...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SLP	$18.27	-0.05%	393.69K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SLP	$18.27	-0.1%	393.69K
3
4
5
6

SLP

SLP

Get Simulations Plus Inc. Data in Excel

Get Simulations Plus Inc. Data in Excel